Societal economic burden of multiple sclerosis and cost-effectiveness of disease-modifying therapies

Overview of attention for article published in Frontiers in Neurology, October 2022

Altmetric Badge

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 4 Dimensions

Readers on

mendeley: 21 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 26,919 followers.

Societal economic burden of multiple sclerosis and cost-effectiveness of disease-modifying therapies: Background In an era of scarce resources, policy makers, neurologists and other stakeholders need to be aware of the economic… #Neurology https://t.co/p4

25 Oct 2022

Reply Repost Favourite

New Research: Societal economic burden of multiple sclerosis and cost-effectiveness of disease-modifying therapies: Background In an era of scarce resources, policy makers, neurologists and other stakeholders need to be aware of the economic… https://t.co

20 Oct 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.